Patents by Inventor Guy Augert

Guy Augert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Promoter of the human fatp5 gene and uses
    Publication number: 20070105115
    Abstract: The invention relates to an isolated human nucleic acid, characterized in that it corresponds to the promoter of the human FATP5 protein, and to an isolated human nucleic acid coding for a protein, particularly for the human FATP5 protein, placed under the dependence of said promoter. The invention further relates to a vector comprising said nucleic acid, or to a host cell into which said nucleic acid or said vector has been introduced. Finally, the invention relates to the use of said nucleic acid, said vector or said host cell in a method of identifying a product capable of modulating the expression of a nucieotide sequence placed under the dependence of said promoter of the human FATP5 protein, and to said method of identification.
    Type: Application
    Filed: August 4, 2004
    Publication date: May 10, 2007
    Applicant: MERCK SANTE
    Inventors: Geneviève Martin, Guy Augert, Maryam Asfari, Herve Dupont, Daniel Ruggiero, Philippe Durbin
  • Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
    Patent number: 6596758
    Abstract: The present invention relates to benzopyrans and benzoxepines of formula (I), wherein X, A, R1, R2 and (R)p have the meanings as given in claim 1, which can be used in the treatment of dislipidaemias, atherosclerosis and diabetes, to pharmaceutical compositions comprising them and to processes allowing the preparation of these compounds.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: July 22, 2003
    Assignee: Merck Patent GmbH
    Inventors: Michel Brunet, Jean-Jaques Zeiller, Jean-Jaques Berthelon, Francis Contard, Guy Augert, Daniel Guerrier
  • N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
    Patent number: 6509362
    Abstract: The present invention relates to the compounds of formula (I) in which X, R1, R2 and R3 are as defined in claim 1. These compounds are cholesteryl acyl transferase (ACAT) inhibitors.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: January 21, 2003
    Assignee: Merck Patent Gesellschaft mit Beschraenkter Haftung
    Inventors: Diedier Festal, Jean Yves Nioche, Guy Augert, Jacques Deserprit
  • New N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
    Publication number: 20020068739
    Abstract: The present invention relates to the compounds of formula (I) in which X, R1, R2 and R3 are as defined in claim 1. These compounds are cholesteryl acyl transferase (ACAT) inhibitors.
    Type: Application
    Filed: November 1, 2001
    Publication date: June 6, 2002
    Applicant: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Diedier Festal, Jean Yves Nioche, Guy Augert, Jacques Deserprit
  • N-phenylamide and N-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
    Patent number: 6339097
    Abstract: The present invention relates to the compounds of formula (I) in which X, R1, R2 and R3 are as defined in claim 1. These compounds are cholesteryl acyl transferase (ACAT) inhibitors.
    Type: Grant
    Filed: June 21, 2000
    Date of Patent: January 15, 2002
    Assignee: Merck Patent GmbH
    Inventors: Diedier Festal, Jean Yves Nioche, Guy Augert, Jacques Deserprit